PINE PHARMACEUTICALS LLC Federal Contracts — Government Award History
Total (All Time)$966,782
Latest FY$209,613
Primary AgencyDepartment of Health and Human Services
PINE PHARMACEUTICALS LLC has received $966,782 in total federal contract awards
across 3 fiscal year(s). ▼ 66.2% vs FY2023 Peak year was FY2023 ($619,295).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2024 | $209,613 | 3건 | Department of Health and Human Services | |
| FY2023 | $619,295 | 6건 | Department of Health and Human Services | |
| FY2022 | $137,874 | 4건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2023-06-30 | Department of Health and Human Services | $230,423 | THE PURPOSE OF THIS ACQUISITION IS TO PROCURE A PINE PHARMACEUTICAL INTRAVENOUS |
| 2016-09-22 | Department of Health and Human Services | $173,631 | DRUG NECESSARY FOR NCATS II 16-AA-0080 PROTOCOL USE |
| 2023-01-05 | Department of Health and Human Services | $170,670 | NIDDK – ACQUISITION OF AN INTRAVENOUS STABLE ISOTOPE |
| 2023-01-01 | Department of Health and Human Services | $138,712 | INTRAVENOUS STABLE ISOTOPES (6,6-D2 GLUCOSE) FOR METABOLIC RESEARCH [23-000014] |
| 2024-09-16 | Department of Health and Human Services | $125,813 | NIDDK: SEVERABLE – ACQUISITION OF INTRAVENOUS STABLE ISOTOPES |
| 2025-06-20 | Department of Health and Human Services | $121,989 | PINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFOR |
| 2024-02-07 | Department of Veterans Affairs | $68,400 | 503B COMPOUNDING PHARMACEUTICALS |
| 2024-10-01 | Department of Veterans Affairs | $68,400 | 503B COMPOUNDING PHARMACEUTICALS |
| 2022-01-27 | Department of Health and Human Services | $65,003 | PINE PHARMACEUTICALS, LLC:1270808 [22-000472] |
| 2023-02-17 | Department of Health and Human Services | $44,606 | NIDDK – ACQUISITION OF INTRAVENOUS STABLE ISOTOPE (D5 GLYCEROL, 6,6 D2-GLUCOSE) |
| 2021-01-05 | Department of Health and Human Services | $41,953 | PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE (POTASSIUM PALMITATE U-13C) FOR METABO |
| 2022-09-06 | Department of Health and Human Services | $33,944 | THE MANUFACTURE OF 4,000 PLACEBO CAPSULES FOR PATIENT USE, AND 4,000 OVER-ENCAPS |
| 2021-05-04 | Department of Health and Human Services | $27,385 | NIDDK – D5 GLYCEROL–3 BATCHES/SHIPMENTS OF 60 EACH |
| 2021-12-14 | Department of Health and Human Services | $26,557 | COMPOUNDING OF 10% POLYSORBATE-80 TO DILUTE TPM-001 INVESTIGATIONAL DRUG FOR TRE |
| 2026-02-17 | Department of Health and Human Services | $24,652 | ATORVASTATIN 40 MG CAPSULES AND PLACEBO CAPSULES, QTY 1,232 BATCH. |
| 2023-09-14 | Department of Health and Human Services | $22,303 | NIDDK – ACQUISITION OF AN INTRAVENOUS STABLE ISOTOPE |
| 2025-10-01 | Department of Veterans Affairs | $20,379 | 503B COMPOUNDING PHARMACEUTICALS |
| 2024-03-01 | Department of Health and Human Services | $15,400 | NIDDK / IV ISOTOPE 6,6 D2GLUCOSE |
| 2022-11-30 | Department of Health and Human Services | $12,581 | NIDDK – ACQUISITION OF INTRAVENOUS STABLE ISOTOPE |
| 2017-07-28 | Department of Health and Human Services | $12,465 | LABORATORY EQUIPMENT,INSTRUMENTS AND SUPPLIES |